6DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus.Ann Intern Med,1999,131 (4) :281-303.
7Melander A. Review of previous impaired glucose tolerance intervention studies. Diabetes Med, 1996,13 ( 3 Suppl 2 ): S20-S22.
8Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.N Engl J Med,2002,346(6) :393-403.
9Chiasson JL, Josse RG, Gomis R, et al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA,2003,290(4) :486-494.
10Hanefeld M, Koehler C, Henkel E, et al. Post-challenge hyperglycemia relates more strongly than fasting hyperglycemia with carotid intimae-media thickness: the RIAD study. Diabet Med, 2000, 17(12) :212-218.
